Back to Search
LYLE MOHR, MD
MD
Surgery Physician
NPI: 1144332438Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only.
PMID 18631251·Hepatol Res·2008
8-other
[Hepatocellular carcinoma: novel therapeutic approaches].
PMID 17455567·Praxis (Bern 1994)·2007
6-review
Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice.
PMID 11339896·Hum Gene Ther·2001
7-preclinical
Rabbit cytochrome P450 4B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma.
PMID 10917203·Cancer Gene Ther·2000
7-preclinical
Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene.
PMID 10706550·Hepatology·2000
4-observational
Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
PMID 17989705·Gene Ther·2008
7-preclinical
The hypoxia altitude simulation test: an increasingly performed test for the evaluation of patients prior to air travel.
PMID 18398113·Chest·2008
8-other
Influence of season and temperature on the relationship of elemental carbon air pollution to pediatric asthma emergency room visits.
PMID 19085586·J Asthma·2008
4-observational
Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression.
PMID 18549308·Hum Gene Ther·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 980 3RD ST STE 100
TILLAMOOK, OR 97141 - Phone
- (503) 842-4033
Quick Facts
- NPI
- 1144332438
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile